Published in Gene Therapy Weekly, June 15th, 2006
"In previous study, we have shown that GaIT V functions as a positive growth regulator in glioma. Here, we reported that down-regulation of the expression of GaIT V in SHG44 cells by transfection with antisense cDNA specifically up-regulated the expression of cell surface integrin beta I without the change of its mRNA, and with integrin beta 1 125 kDa mature form increased and 105 kDa precursor form decreased," wrote X.N. Chen and colleagues, Fudan University.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-06-15)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.